Literature DB >> 17497773

Optimized relaxivity and stability of [Gd(H(2,2)-1,2-HOPO)(H2O)]- for use as an MRI contrast agent.

Christoph J Jocher1, Mauro Botta, Stefano Avedano, Evan G Moore, Jide Xu, Silvio Aime, Kenneth N Raymond.   

Abstract

Relaxometry and solution thermodynamic measurements show that Gd(H(2,2)-1,2-HOPO) is a good candidate as a contrast agent for magnetic resonance imaging (MRI-CA). Acidic, octadentate H(2,2)-1,2-HOPO forms a very stable Gd(III) complex [pGd=21.2(2)]. The coordination sphere at the Gd(III) center is completed by one water molecule that is not replaced by common physiological anions. In addition, this ligand is highly selective for Gd(III) binding in the presence of Zn(II) or Ca(II). The symmetric charge distribution of the 1,2-HOPO chelates is associated with favorably long electronic relaxation time T1,2e comparable to those of GdDOTA. This, in addition to the fast water exchange rate typical of HOPO chelates, improves the relaxivity to r1p=8.2 mM-1 s-1 (0.47 T). This remarkably high value is unprecedented for small-molecule, q=1 MRI-CA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17497773      PMCID: PMC3188310          DOI: 10.1021/ic700399p

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  11 in total

1.  Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications.

Authors:  P Caravan; J J Ellison; T J McMurry; R B Lauffer
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

Review 2.  Next generation, high relaxivity gadolinium MRI agents.

Authors:  Kenneth N Raymond; Valérie C Pierre
Journal:  Bioconjug Chem       Date:  2005 Jan-Feb       Impact factor: 4.774

3.  Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents.

Authors:  Sophie Laurent; Luce Vander Elst; Robert N Muller
Journal:  Contrast Media Mol Imaging       Date:  2006 May-Jun       Impact factor: 3.161

4.  "Cymothoe sangaris": an extremely stable and highly luminescent 1,2-hydroxypyridinonate chelate of Eu(III).

Authors:  Evan G Moore; Jide Xu; Christoph J Jocher; Eric J Werner; Kenneth N Raymond
Journal:  J Am Chem Soc       Date:  2006-08-23       Impact factor: 15.419

Review 5.  Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.

Authors:  Peter Caravan
Journal:  Chem Soc Rev       Date:  2006-05-03       Impact factor: 54.564

6.  Substituent effects on Gd(III)-based MRI contrast agents: optimizing the stability and selectivity of the complex and the number of coordinated water molecules.

Authors:  Valérie C Pierre; Mauro Botta; Silvio Aime; Kenneth N Raymond
Journal:  Inorg Chem       Date:  2006-10-02       Impact factor: 5.165

7.  Highly soluble tris-hydroxypyridonate Gd(III) complexes with increased hydration number, fast water exchange, slow electronic relaxation, and high relaxivity.

Authors:  Eric J Werner; Stefano Avedano; Mauro Botta; Benjamin P Hay; Evan G Moore; Silvio Aime; Kenneth N Raymond
Journal:  J Am Chem Soc       Date:  2007-01-30       Impact factor: 15.419

8.  Gadolinium(III) 1,2-hydroxypyridonate-based complexes: toward MRI contrast agents of high relaxivity.

Authors:  Jide Xu; David G Churchill; Mauro Botta; Kenneth N Raymond
Journal:  Inorg Chem       Date:  2004-09-06       Impact factor: 5.165

9.  Toward optimized high-relaxivity MRI agents: the effect of ligand basicity on the thermodynamic stability of hexadentate hydroxypyridonate/catecholate gadolinium(III) complexes.

Authors:  Dan M J Doble; Marco Melchior; Brendon O'Sullivan; Carsten Siering; Jide Xu; Valérie C Pierre; Kenneth N Raymond
Journal:  Inorg Chem       Date:  2003-08-11       Impact factor: 5.165

10.  1,2-hydroxypyridonates as contrast agents for magnetic resonance imaging: TREN-1,2-HOPO.

Authors:  Christoph J Jocher; Evan G Moore; Jide Xu; Stefano Avedano; Mauro Botta; Silvio Aime; Kenneth N Raymond
Journal:  Inorg Chem       Date:  2007-10-03       Impact factor: 5.165

View more
  6 in total

1.  Gd@C82 metallofullerenes for neutron capture therapy-fullerene solubilization by poly(ethylene glycol)-block-poly(2-(N, N-diethylamino)ethyl methacrylate) and resultant efficacy in vitro.

Authors:  Yukichi Horiguchi; Shinpei Kudo; Yukio Nagasaki
Journal:  Sci Technol Adv Mater       Date:  2011-07-07       Impact factor: 8.090

2.  Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents.

Authors:  Peter Caravan; Christian T Farrar; Luca Frullano; Ritika Uppal
Journal:  Contrast Media Mol Imaging       Date:  2009 Mar-Apr       Impact factor: 3.161

3.  Correlation of relaxivity with coordination number in six-, seven-, and eight-coordinate Mn(II) complexes of pendant-arm cyclen derivatives.

Authors:  Sen Wang; T David Westmoreland
Journal:  Inorg Chem       Date:  2009-01-19       Impact factor: 5.165

Review 4.  The importance of water exchange rates in the design of responsive agents for MRI.

Authors:  A Dean Sherry; Yunkou Wu
Journal:  Curr Opin Chem Biol       Date:  2013-01-17       Impact factor: 8.822

Review 5.  Responsive MRI agents for sensing metabolism in vivo.

Authors:  Luis M De Leon-Rodriguez; Angelo Josue M Lubag; Craig R Malloy; Gary V Martinez; Robert J Gillies; A Dean Sherry
Journal:  Acc Chem Res       Date:  2009-07-21       Impact factor: 22.384

6.  1,2-hydroxypyridonate/terephthalamide complexes of gadolinium(III): synthesis, stability, relaxivity, and water exchange properties.

Authors:  Eric J Werner; Julia Kozhukh; Mauro Botta; Evan G Moore; Stefano Avedano; Silvio Aime; Kenneth N Raymond
Journal:  Inorg Chem       Date:  2009-01-05       Impact factor: 5.165

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.